Researchers in the USA have postulated a link between a bacterial infection and the development of coronary artery disease. The scientists, from the University of Utah and Latter Day Saints Hospital in Salt Lake City, say they have detected Chlamydia pneumoniae in 73% of 90 patients who underwent coronary atherectomy. Cardiologist Joseph Muhlestein noted that while the findings don't prove a link, they do lend credence to the hypothesis that an infectious agent triggers the condition in many patients by injuring the interior arterial wall and making it vulnerable to pathological changes such as fat deposition.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze